Abstract

SMi is thrilled to announce the expansion of its antimicrobial portfolio of events across the Atlantic with the release of Superbugs & Superdrugs USA, complementing the Groupa€™s sell out Superbugs & Superdrugs European conference which has been running for the past 18 years. With huge interest from leaders in the field including pending confirmations from PAHO/WHO, Astra Zeneca and other senior industry representatives, we have worked closely with an expert panel of speakers to present an agenda that is shaping up to be the best Superbugs & Superdrugs event to date. Some of those who have confirmed include: BARDA, NIH, Janssen, Blueberry Therapeutics +more!